Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
Cancer researchers have long recognized that somatic mutations are not uniformly distributed within genes. However, most approaches for identifying cancer mutations focus on either the entire-gene or single amino-acid level. We have bridged these two methodologies with a multiscale mutation clustering algorithm that identifies variable length mutation clusters in cancer genes. We ran our algorithm on 539 genes using the combined mutation data in 23 cancer types from The Cancer Genome Atlas (TCGA) and identified 1295 mutation clusters. The resulting mutation clusters cover a wide range of scales and often overlap with many kinds of protein features including structured domains, phosphorylation sites, and known single nucleotide variants. We statistically associated these multiscale clusters with gene expression and drug response data to illuminate the functional and clinical consequences of mutations in our clusters. Interestingly, we find multiple clusters within individual genes that have differential functional associations: these include PTEN, FUBP1, and CDH1. This methodology has potential implications in identifying protein regions for drug targets, understanding the biological underpinnings of cancer, and personalizing cancer treatments. Toward this end, we have made the mutation clusters and the clustering algorithm available to the public. Clusters and pathway associations can be interactively browsed at m2c.systemsbiology.net. The multiscale mutation clustering algorithm is available at https://github.com/IlyaLab/M2C.
Institute for Systems Biology, Seattle, WA, United States of America.
William
W
Poole
Institute for Systems Biology, Seattle, WA, United States of America.
Kalle
K
Leinonen
Institute for Systems Biology, Seattle, WA, United States of America.
Ilya
I
Shmulevich
Institute for Systems Biology, Seattle, WA, United States of America.
Theo A
TA
Knijnenburg
Institute for Systems Biology, Seattle, WA, United States of America.
Brady
B
Bernard
D000465:Algorithms; D002874:Chromosome Mapping; D004252:DNA Mutational Analysis / Q000379:methods*; D004273:DNA, Neoplasm / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D052138:Genes, Neoplasm / Q000235:genetics; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D005810:Multigene Family / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics*
D004273:DNA, Neoplasm